Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats-Reference-Cited by-同舟云学术

Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats

Published:2013-06-18 Issue:7 Volume:28 Page:1641-1652
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Ma Xue¹,Meng Jingru¹,Jia Min¹,Bi Long²,Zhou Ying¹,Wang Yukun¹,Hu Jing³,He Gonghao⁴,Luo Xiaoxing¹

Affiliation:

1. Department of Pharmacology; School of Pharmacy, Fourth Military Medical University; Xi'an China

2. Institute of Orthopaedics and Traumatology; Xijing Hospital, Fourth Military Medical University; Xi'an China

3. Department of Histology and Embryology; Fourth Military Medical University; Xi'an China

4. Department of Pharmacy; Kunming General Hospital of Chengdu Military Region; Kunming China

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference51 articles.

1. Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation;Rauner;Age (Dordr).,2008

2. Update in osteoporosis and metabolic bone disorders;Shoback;J Clin Endocrinol Metab.,2007

3. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis;Li;J Bone Miner Res.,2009

4. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives;Baron;J Clin Endocrinol Metab.,2012

5. Osteoporosis and diabetes mellitus;Inzerillo;Rev Endocr Metab Disord.,2004

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Glycemic Control: GLP-1 Receptor Agonists and Their Impact on Calcium Homeostasis in Real-World Patients;Journal of Clinical Medicine;2024-08-19

2. Bone Fragility in Diabetes and its Management: A Narrative Review;Drugs;2024-08-05

3. Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models;Peptides;2024-07

4. Gut hormones and bone homeostasis: potential therapeutic implications;Nature Reviews Endocrinology;2024-06-10

5. Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial;eClinicalMedicine;2024-06